Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 5/20 | 0.45 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537733 | 1.00 | KDM4E (0.46) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL11050977 | 0.93 | CNR2 (0.45) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL7655901 | 0.89 | CNR2 (0.40) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL7653734 | 0.89 | CYP1A2 (0.56) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL7654487 | 0.89 | CNR2 (0.40) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL18242398 | 0.87 | CNR2 (0.42) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL7653729 | 0.87 | CNR2 (0.39) | KDM4EALDH1A1GAAHPGDCNR2 | |
| SCHEMBL27342867 | 0.87 | IDO1 (0.54) | KDM4ECNR2 | |
| SCHEMBL19248499 | 0.85 | TLR8 (0.44) | CNR2CNR1 | |
| SCHEMBL11057507 | 0.85 | ALDH1A1 (0.41) | KDM4EALDH1A1GAAHPGDCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441901-B2 | Quantum dot ink composition, and quantum dot electroluminescent device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-14 | — | — | US | disclosed |
| US-20230287231-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230257607-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| EP-1262469-B1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-7901594-B2 | Electroconductivity | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| CN-100387681-C | Functional film | JAPAN SCIENCE & TECH CORP (JP) | 2008-05-14 | — | — | CN | disclosed |
| CN-1643106-A | Functional film | JAPAN SCIENCE & TECH CORP (JP) | 2005-07-20 | — | — | CN | disclosed |
| US-20030116755-A1 | Polyacene derivatives and production thereof | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1262469-A1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | Japan Science and Technology Corporation (JP) | 2002-12-04 | — | — | EP | disclosed |
| US-4003589-A | MICROCAPSULES OF NAPHTHALENE SOLVENT AND DYES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030116755-A1 | Polyacene derivatives and production thereof | CBR1, HVCN1, H1-0 | KDM4E 1200/4885ALDH1A1 591/4885GAA 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.